Stamford, CT -- (SBWIRE) -- 01/18/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Bacterin International Holdings Inc (NYSEMKT:BONE), Prosensa Holding NV (NASDAQ:RNA), DARA Biosciences Inc (NASDAQ:DARA), Stereotaxis Inc (NASDAQ:STXS).
Bacterin International Holdings Inc (NYSEMKT:BONE) opened its last trade at the price of $0.64. Its closing price was $0.760 after gaining 16.92% for the day. The company traded with the total volume of 1.24 million shares, while its average trading volume remained 240,640.00 shares. The beta of this stock stands at 2.79. Bacterin International Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The company’s products are used in various applications.
For How Long BONE will Fight for Profitability? Read This Trend Analysis report
Prosensa Holding NV (NASDAQ:RNA) percentage change plunged -7.91% to close at $6.34 with the total traded volume of 1.23 million shares, along with average volume of 516,965.00 shares. The 52 week range of the stock remained $3.43 - $34.55, while its day lowest price was $6.25. The share price hit the day highest price of $7.10. Prosensa Holding B.V., a biotechnology company, engages in the discovery and development of ribonucleic acid-modulating therapeutics for the treatment of genetic disorders. The company’s products focus on the treatment of neuromuscular and neurodegenerative disorders, including duchenne muscular dystrophy (DMD), myotonic dystrophy, and Huntington’s diseases.
Has RNA Found The Bottom And Ready To Gain Momentum? Find Out Here
DARA Biosciences Inc (NASDAQ:DARA) traded on volume of 1.18 million shares in the last session against average volume of 1.63 million shares. The company started its trading session with the price of $0.76 and closed at $0.720 by scoring -5.26%. DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates.
Why Should Investors Buy DARA After the Recent Fall? Just Go Here and Find Out
Stereotaxis Inc (NASDAQ:STXS) started its last trading session with the price of $1.17 and closed at $5.33 by scoring +6.81%. The stock traded with total volume of 1.17 million shares, while the average trading volume remained 1.07 million shares. The beta value of this stock stands at 2.57. Day range for the stock was $4.95 - $5.44. Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to navigate catheters, guidewires, and other delivery devices through the blood vessels and heart chambers to treatment sites.
Why Should Investors Buy STXS After The Recent Gain? Just Go Here and Find Out
About Wall Street Pennies
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)